Novel Agents in the Treatment of Relapsed or Refractory Peripheral T-Cell Lymphoma

Article ID	Journal	Published Year	Pages	File Type
5664315	Hematology/Oncology Clinics of North America	2017	17 Pages	PDF

Keywords

Histone deacetylase (HDAC) inhibitors Epigenetic Pralatrexate antibody drug conjugates

Related Topics

Health Sciences Medicine and Dentistry Hematology

$Novel Agents in the Treatment of Relapsed or Refractory Peripheral T-Cell Lymphoma$

Authors

Enrica MD, PhD, Alexander G. MD, Owen A. MD, PhD,